Blazing the trail for innovative tuberculosis diagnostics.

"Declarations Conflict of interestAuthors declare no financial conflict of interest. P.N., A.C., and C.D. are the principal investigators of the R2D2 TB Network. S.Y., T.B., C.I, and D.B., A.G. are consultants or staff of the R2D2 TB Network. T.B. holds patents in the fields of LAM detection and aerosol collection, and is a shareholder of Avelo Ltd, a Swiss diagnostics company. C.I. is the founder and director of Connected Diagnostics Limited, a UK-based commercial entity that assists companies with the development of diagnostic devices. D.B. is the chief medical officer of Hemex Health, a diagnostics development company, and consults for other diagnostic entities. Conflict of interest Authors declare no financial conflict of interest. P.N., A.C., and C.D. are the principal investigators of the R2D2 TB Network. S.Y., T.B., C.I, and D.B., A.G. are consultants or staff of the R2D2 TB Network. T.B. holds patents in the fields of LAM detection and aerosol collection, and is a shareholder of Avelo Ltd, a Swiss diagnostics company. C.I. is the founder and director of Connected Diagnostics Limited, a UK-based commercial entity that assists companies with the development of diagnostic devices. D.B. is the chief medical officer of Hemex Health, a diagnostics development company, and consults for other diagnostic entities."

"Funding Open Access funding enabled and organized by Projekt DEAL. This work is funded by the National Institutes of Health (NIH) (funding reference number U01AI152087; Rapid Research in Diagnostics Development for Tuberculosis Network)."